tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

Bit Digital (BTBT) Q2 2026 Earnings Call: Cloud Growth, White Fiber Financing and Buyback Review

Bit Digital Q2 2026 revenue rose 15% to $32.1 million as cloud services expanded, while management reviewed White Fiber financing and a potential buyback.
iconBit Digital Inc
TradingKey
5 hours ago

Brookfield Corporation (BN) Q2 2026 Earnings Call: DE Rises 15% as AI and Insurance Expand

Brookfield Corporation’s Q2 2026 earnings call covered 15% DE growth, record fundraising, $190 billion of insurance assets and expanding AI infrastructure plans.
iconBrookfield Corp
TradingKey
5 hours ago

Bullish (BLSH) Q2 2026 Earnings Call: Revenue Up 62%, Tokenization Advances

Bullish Q2 2026 adjusted revenue rose 62% to $92.6 million as management advanced tokenized equities, U.S. derivatives access and Equiniti.
iconBullish
TradingKey
5 hours ago

Belite Bio (BLTE) Q2 2026 Earnings Call: Tinlarebant FDA Review and $780M Cash

Belite Bio Q2 2026 earnings call: FDA priority review for Tinlarebant, a February 12, 2027 PDUFA date, $780 million in cash and higher expenses.
iconBelite Bio Inc
TradingKey
5 hours ago

Bridgeline Digital (BLIN) Q3 FY2026 Earnings Call: Core Revenue Growth Narrows Losses

Bridgeline Digital’s Q3 FY2026 revenue rose to $3.9 million, core revenue reached $2.4 million, and adjusted EBITDA loss narrowed to $102,000.
iconBridgeline Digital Inc
TradingKey
5 hours ago

Birkenstock (BIRK) Fiscal Q3 2026 Earnings Call: Revenue Guidance Raised

Birkenstock fiscal Q3 2026 revenue rose 15% in constant currency as DTC accelerated. Management raised full-year EBITDA guidance to at least €710 million.
iconBirkenstock Holding PLC
TradingKey
5 hours ago

Biofrontera (BFRI) Q2 2026 Earnings Call: Revenue Up 33%, Gross Margin Reaches 80%

Biofrontera’s Q2 2026 earnings call covered 33% revenue growth, an 80% gross margin, near-breakeven adjusted EBITDA, ITC restrictions and Ameluz milestones.
iconBiofrontera Inc
TradingKey
5 hours ago

AVAX One (AVX) Q2 2026 Earnings Call: Revenue Rises as Digital Asset Losses Weigh

AVAX One Q2 2026 revenue rose to $2.8 million, while digital asset losses drove a $35.1 million net loss. Review liquidity, staking and AI plans.
iconAvax One Technology Ord Shs
TradingKey
5 hours ago

BETA Technologies Q2 2026 Earnings Call: Revenue Growth, $3.9 Billion Backlog and Higher Guidance

BETA Technologies Q2 2026 earnings call: revenue rose 146% to $14.7 million, backlog reached $3.9 billion, and full-year guidance increased.
iconBETA Technologies Inc
TradingKey
5 hours ago

HeartBeam (BEAT) Q2 2026 Earnings Call: FDA Filing, Lower Cash Burn and Commercial Launch

HeartBeam’s Q2 2026 earnings call covered a $5 million net loss, lower cash burn, FDA progress and early commercial rollout across four U.S. markets.
iconHeartbeam Inc
TradingKey
5 hours ago

Birch Tech (BCHT) Q2 2026 Earnings Call: Revenue Reaches $3.8M

Birch Tech’s Q2 2026 earnings call covered $3.8 million in revenue, a $3.0 million net loss, patent resolutions and plans to scale water treatment.
iconBirchtech Ord Shs
TradingKey
5 hours ago

BioCardia (BCDA) Q2 2026 Earnings Call: CardiAMP Japan Filing and FDA Progress

BioCardia’s Q2 2026 earnings call covered Japan’s CardiAMP filing, FDA pathways for CardiAMP and Helix, a narrower net loss and cash runway into 2027.
iconBioCardia Inc
TradingKey
5 hours ago

Atea Pharmaceuticals (AVIR) Q2 2026 Earnings Call: C-BEYOND Meets Phase 3 Endpoint

Atea Pharmaceuticals’ Q2 2026 earnings call covered positive Phase 3 C-BEYOND HCV data, $219.5 million in cash and key 2027 regulatory milestones.
iconAtea Pharmaceuticals Inc
TradingKey
5 hours ago

AEVEX (AVEX) Q2 2026 Earnings Call: Revenue Doubles, Guidance Raised, BlackSea Deal Announced

AEVEX (AVEX) Q2 2026 earnings call: revenue rose 100% to $201.8 million, FY2026 guidance increased, and a $650 million BlackSea deal was announced.
iconAEVEX Ord Shs Class A (Proposed)
TradingKey
5 hours ago

Aveanna Healthcare (AVAH) Q2 2026 Earnings Call: Guidance Raised on Organic Growth

Aveanna Healthcare’s Q2 2026 earnings call covered 13.7% revenue growth, higher 2026 guidance, California rate gains and stronger long-term growth targets.
iconAveanna Healthcare Holdings Inc
TradingKey
5 hours ago

AOSL Fiscal Q4 2026 Earnings Call: AI Growth Drives Mix, September Guidance at $176M

AOSL fiscal Q4 2026 earnings call: revenue reached $170.4 million, AI and server demand strengthened, and September revenue guidance was $176 million.
iconAlpha and Omega Semiconductor Ltd
TradingKey
5 hours ago

Arrive AI (ARAI) Q2 2026 Earnings Call: AP3 Plus Ramp and Commercial Pipeline

Arrive AI reports Q2 2026 revenue of $14,700, a $14.1 million net loss, $5.1 million in liquidity and AP3 Plus shipments targeted for September.
iconArrive AI Inc
TradingKey
5 hours ago

Ampco-Pittsburgh (AP) Q2 2026 Earnings Call: Profit Returns, Backlog Hits $385.4M

Ampco-Pittsburgh’s Q2 2026 earnings call detailed a return to profit, $9.8 million in adjusted EBITDA and backlog growth to $385.4 million.
iconAmpco-Pittsburgh Corp
TradingKey
5 hours ago

Andersen Group (ANDG) Q2 2026 Earnings Call: Organic Growth Reaches 20.6%

Andersen Group Q2 2026 revenue rose 23.7% to $217.7 million as organic growth reached 20.6%. The company reaffirmed its full-year guidance.
iconAndersen Group Ord Shs Class A
TradingKey
5 hours ago

American Shared Hospital Services (AMS) Q2 2026 Earnings Call: Revenue Rises 19.2%

American Shared Hospital Services’ Q2 2026 earnings call covered 19.2% revenue growth, $4.4 million in operating cash flow, refinancing and receivable risks.
iconAmerican Shared Hospital Services
TradingKey
5 hours ago
Featured Tools
marketing_marketsTitleMarketscalendar_economicCalendarEconomic Calendarsearch.intelligent.strategySmartPicksarticle_asider_weekly_reportWeekly Report
Popular Instruments
link
Name
Price
Chg%
US30
US30
US30
--
--
NAS100
NAS100
NAS100
--
--
SPX500
SPX500
US500
--
--
Top News
link
Google Launches Gemini 3.7 Flash: Major Leap in Coding and Agent Capabilities, Three-Week Iteration Sets New Speed Record for Low-Cost Models
【US Pre-Market】PPI in Focus After CPI Cools; Cisco Drops Over 6%, Applied Materials Earnings in Spotlight
Micron Stock Forecast: Can AI Memory Demand Push MU Above $1,000?
US Stocks Close: S&P 500 Hits Record High, Nasdaq Gains for Second Day; Memory Stocks Lead as SanDisk Surges Over 13%
Oracle Stock Forecast: ORCL Faces Layoffs, $70B Capex and Rising Debt
Market Movers
link
Natural Gas (NATGAS) Moved Sharply on Aug 14: Inventories, the Dollar, or Geopolitics?
50 minutes ago
NATGAS
--
BNB (BNBUSD) Is down 1.05% on Aug 14: Why It Happened
2 hours ago
BNBUSD
--
Solana (SOLUSD) Is down 1.08% on Aug 14: Why It Happened
2 hours ago
SOLUSD
--
NZD/USD (NZDUSD) Is up 0.52% on Aug 14: What Signals Does the Macro Data Send?
4 hours ago
NZDUSD
--
WTI Futures (USOIL-F) Surges on Aug 14: Key Factors to Watch
6 hours ago
USOIL-F
--
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy